AstraZeneca’s (AZN) CARES Phase III Clinical Programme Fails to Meet Primary End Point

1 hour ago 1

Noor Ul Ain Rehman

Tue, June 2, 2026 astatine 9:14 AM CDT 2 min read

AstraZeneca PLC (NYSE:AZN) is 1 of the champion stocks to bargain present for agelong word growth. AstraZeneca PLC (NYSE:AZN) reported connected May 29 that the planetary CARES Phase III objective programme showed that attraction with anselamimab led to “nominally statistically important and highly clinically meaningful payment successful adults with precocious kappa airy concatenation (AL) amyloidosis arsenic first-line therapy added to modular of attraction plasma compartment dyscrasia (PCD) treatments, compared to placebo”. Anselamimab is simply a imaginable first-in-class anti-fibril therapy. The institution added that successful the wide colonisation of patients with AL amyloidosis, attraction with anselamimab did not conscionable the superior endpoint, defined arsenic “a hierarchical operation of clip to all-cause mortality (ACM) and frequence of cardiovascular hospitalisations (CVH), arsenic antecedently disclosed”.

AstraZeneca’s (AZN) Dividend: Resilient, Predictable, and Built connected Innovation

In a abstracted development, AstraZeneca PLC (NYSE:AZN) reported connected May 28 that its Imfinzi (durvalumab), successful operation with Bacillus Calmette-Guérin (BCG) induction and attraction therapy, received support by the FDA successful the U.S. to dainty big patients with BCG-naïve, high-risk non-muscle-invasive bladder crab (NMIBC). Management stated that the FDA’s support is based connected affirmative results from the POTOMAC Phase III trial.

AstraZeneca PLC (NYSE:AZN) is simply a biopharmaceutical institution that explores, develops, manufactures, and commercializes medicine medicines. It supplies its products and services to specialty and superior attraction physicians, and is progressive successful exploring caller immuno-oncology attraction approaches. AstraZeneca PLC (NYSE:AZN) distributes its products and services done section typical offices and distributors.

While we admit the imaginable of AZN arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 15 Stocks That Will Make You Rich successful 10 Years AND 12 Best Stocks That Will Always Grow.

Disclosure: None. Follow Insider Monkey connected Google News.

Read Entire Article